The Pharmaceutical factory of the future was defined including a systems architecture that is both flexible, scaleable and affordable.  Both leveraging industry standards and some internal standardization were incorporated.  This strategic document is driving their capital budgets for their plants worldwide.  The company is keeping their operations in-line with current and future plans involving automation, technology and best practices.  There was consideration of outsourcing large portions of manufacturing, but the strategy gave the senior executive team the confidence and influence to keep manufacturing domestically.